Clinics in Dermatology
Volume 26, Issue 4 , Pages 347-357 , July 2008

Flavonoids as components of biologically active cosmeceuticals

  • Jacek Arct, PhD

      Affiliations

    • Warsaw University of Technology, Warsaw, Poland
    • Academy of Cosmetics and Health Care, Warsaw, Poland
    • Corresponding Author InformationCorresponding author. 13 Podwale Str, 00-252 Warsaw, Poland.
    • ,
  • Katarzyna Pytkowska, MSc

      Affiliations

    • Academy of Cosmetics and Health Care, Warsaw, Poland

References 

  1. Cosmetics Directive 76/768/EEC.
  2. Bohm BA. In: Introduction to flavonoids. Amsterdam: Hardwood Academic Publisher; 1998;p. 496
  3. Andersen OM, Markham KR. In: Flavonoids chemistry, biochemistry and applications. Boca Raton (Fla): CRC Press; 2006;p. 1256
  4. In:  Rice-Evans CA,  Packer L editor. Flavonoids in health and disease. New York: Marcel Dekker; 1998;p. 523
  5. Haslam E. In: Practical polyphenolics. Cambridge: Cambridge University Press; 1998;p. 438
  6. Merfort I, Heilmann J. In vivo skin penetration studies of camomile flavones. Pharmazie. 1994;49:509–511
  7. Saija A, Tomaino A. Influence of different penetration enhancers on in vitro skin permeation and in vivo photoprotective effect of flavonoids. Int J Pharm. 1998;175:85–94
  8. Arct J, Oborska A. Common cosmetic hydrophilic ingredients as penetration modifiers of flavonoids. Int J Cosmet Sci. 2002;24:357–366
  9. Jovanovic SV, Steenhen S, Simic MO, Hara Y. Antioxidant properties of flavonoids. In:  Rice-Evans CA,  Packer L editor. Flavonoids in health and disease. New York: Marcel Dekker; 1998;p. 137–162
  10. Kanner J, Frankel E, Granit R, German B, Kinsella EJ. Natural antioxidants in grapes and vines. J Agric Food Chem. 1994;42:64–69
  11. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341–390
  12. Burkitt MJ. Copper-DNA adducts. In:  Packer L editors. Methods in enzymology 234. San Diego: Academic Press; 1994;p. 704
  13. Charlton AJ, Baxter NJ, Khan ML, et al. Polyphenol/peptide binding and precipitation. J Agric Food Chem. 2002;50:1593–1601
  14. Jez JM, Bowman ME, Noel JP. Role of hydrogen bonds in the reaction mechanism of chalcone isomerase. Biochemistry. 2002;41:5168–5176
  15. Havsteen BH. The biochemistry and medical significance of flavonoids. Pharmacol Ther. 2002;96:67
  16. Dangles O, Dufour C. Flavonoid-protein interactions. In:  Andersen OM,  Markham KR editor. Flavonoids—chemistry, biochemistry and applications. Boca Raton (Fla): CRC Press; 2006;p. 443–470
  17. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor. Endocrinology. 1998;139:4252–4263
  18. Kostelac D, Rechkemmer G, Briviba K. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem. 2003;51:7632–7635
  19. Wiliams C, Harborne J, Geiger H, Hoult R. The flavonoids of Tanacetum parthenium and T. vulgare and their anti- inflammatory properties. Phytochemistry. 1999;51:417–423
  20. Guardia T, Rotelli A, Juarez A, Pelzer A. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco. 2001;56:683–687
  21. van Acker SABE, Tromp MNJL, Haenen GRMM, van der Vijgh WJF, Bast A. Flavonoids as scavenger of nitric oxide radical. Biochem Biophys Res Commun. 1995;214:755–759
  22. Virgili F, Kobuchi H, Packer L. Nitrogen monooxide (NO) metabolism: antioxidant properties and modulation of inducible no synthase activity in activated macrophages by procyanidins extracted from pinus maritima. In:  Rice-Evans CA,  Packer L editor. Flavonoids in health and disease. New York: Marcel Dekker; 1998;p. 421–436
  23. Garg A, Garg S, Zaneveld LJD, Singla AK. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res. 2001;15:655–669
  24. Benavente-Garciìa O, Castillo J, Marin FR, OrtunÞo A, Del Riìo JA. Uses and properties of citrus flavonoids. J Agric Food Chem. 1997;45:X–4515
  25. Remien J, Felix W. Influence of the flavonoid Na (+) apicatechine 2 sulfonate on the reactivity the circulation in cats. Arzneimittelforschung. 1974;24:19–22
  26. Pearson DA, Holt RR, Rein O, Paglieroni JL, Schmitz HH, Keen CL. Flavanols and platelet reactivity. Clin Dev Immunol. 2005;12:1–9
  27. Pignatelli P, Pulcinelli FM, Celestini A, et al. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing ten intracellular production of hydrogen peroxide. Am J Clin Nutr. 2000;72:1150–1155
  28. Kobzar G, Mardla V, Samel N. Effects of a-tocopherol, L-arginine, and quercetin on aggregation of human platelets. Nutr Res. 2005;25:569–575
  29. Murray RK, Granner DK, Mayes PA, Rodwell VW. In: Biochemia harpera. Warsaw: PZWL; 1995;p. 955
  30. Zheng YN, Zhang J, Han LK, et al. Effects of compounds in leaves of Salix matsudana on arachidonic acid metabolism. Yakugaku Zasshi. 2005;125:1005–1008
  31. Odotunya G, Hoult JRS, Houghton PJ. Structure-activity relationship for antiinflammatory effect of luteolin and its derived glycosides. Phytother Res. 2005;19:782–786
  32. Sekiya K, Okuda H. Selective inhibition of platelet lipoxygenase by baicalein. Biochem Biophys Res Comm. 1982;105:1090–1095
  33. Tzeng SH, Ko WC, Ko FN, Teng CM. Inhibition of platelet aggregation by some flavonoids. Thromb Res. 1991;64:91–100
  34. Corvazier E, Maclouf J. Interference of some flavonoids and nonsteroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. Biochim Biophys Acta. 1985;835:315–321
  35. Sheu JR, Hsiao G, Chou PH, Shen MY, Chou DS. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. J Agric Chem. 2004;52:4414–4418
  36. Dehmlow C, Murawski N, de Groot H. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sci. 1996;58:1591–1600
  37. Weng JR, Chan SC, Lu YH, et al. Antiplatelet prenylflavonoids from Artocarpus communis. Phytochemistry. 2006;67:824–829
  38. Guerrero JA, Lozano ML, Castillo J, et al. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost. 2005;3:369–376
  39. Kang WS, Chang KH, Chung JH, et al. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J Cardiovasc Pharmacol. 2001;38:875–884
  40. Balestrieri ML, Castaldo D, Balestrieri C, Quagliuolo L, Giovane A, Servillo L. Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. J Lipid Res. 2003;44:380–387
  41. Alexandrakis M, Singh L, Boucher W, et al. Differential effect of flavonoids on inhibition of secretion and accumulation of secretory granules in rat basophilic leukemia cells. Int J Immunopharmacol. 1999;21:379–390
  42. Harborne JB, Williams CA. Advances in flavonoid research since 992. Phytochemistry. 2000;55:481–504
  43. Kuppusamy UR, Khoo HE, Das NP. Structure-activity studies of flavonoids as inhibitors of hyaluronidase. Biochem Pharmacol. 1990;40:397–401
  44. Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Archiv der Pharmazie. 1995;328:720–724
  45. Wilkinson JA, Brown AMG. Horse chestnut—Aesculus hippocastanum: potential applications in cosmetic skin-care products. Int J Cosmet Sci. 1999;21:437–447
  46. Hertel W, Peschel G, Ozegowski JH, Mueller PJ. Inhibitory effects of triterpenes and flavonoids on the enzymatic activity of hyaluronic acid-splitting enzymes. Archiv der Pharmazie. 2006;339:313–318
  47. Kwak WJ, Han CK, Son KH, et al. Effects of Ginkgetin from Ginkgo biloba leaves on cyclooxygenases and in vivo skin inflammation. Planta Medica. 2002;68:316–321
  48. Han CK, Son MJ, Chang HW, Chi YS, Park H, Kim HP. Inhibition of prostaglandin production by a structurally-optimized flavonoid derivative, 2′,4′,7-trimethoxyflavone and cellular action mechanism. Biol Pharm Bull. 2005;28:1366–1370
  49. Fernandez MT, Mira ML, Florencio MH, Jennings KR. Iron and copper chelation by flavonoids: an electrospray mass spectrometry study. J Inorg Biochem. 2002;92:105–111
  50. Moroney MA, Alcaraz MJ, Forder RA, Carey F, Hoult JRS. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J Pharm Pharmacol. 1988;40:787–792
  51. Yamada K, Shoji K, Mori M, et al. Structure-activity relationship of polyphenols on inhibition of chemical mediator release from rat peritoneal exudate cells. In Vitro Cell Dev Biol Anim. 1999;35:169–174
  52. Middleton E, Drzewiecki G. Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochem Pharmacol. 1984;33:3333–3338
  53. Kempuraj D, Madhappan B, Christodoulou S, et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol. 2005;145:934–944

PII: S0738-081X(08)00005-9

doi: 10.1016/j.clindermatol.2008.01.004

Clinics in Dermatology
Volume 26, Issue 4 , Pages 347-357 , July 2008

Article Tools

* Image Usage & Resolution